MedTech Association Appoints 12 to its Board of Directors

Thursday, December 4, 2014


MedTech Association, the Syracuse-based trade association for the bioscience and medical technology industry in New York, has added twelve community and industry leaders to its 2014-2015 board of directors.

Two Syracuse-area executives were named to the board:

• Jeffrey Trubia, a partner with Testone, Marshall & Discenza LLP.

• Sarah Oliker, assistant general counsel at ConMed Corp.

Three Albany-area executives were named to the board:

• Mark Frost, executive vice president and chief financial officer of AngioDynamics Inc.

• Glenn Monastersky, director of operations and associate center director at Rensselaer Polytechnic Institute's Center for Biotechnology & Interdisciplinary Studies.

• Michael Williams, senior director and assistant general counsel of Regeneron Pharmaceuticals.

Four Rochester-area executives were named to the board:

• Dan Carlson, senior director of Rochester site operations for Ortho Clinical Diagnostics.

• Greg Gdowski, executive director of the Center of Medical Technology and Innovation at the University of Rochester.

• Phil McLellan, vice president, Global Operations, Laboratory Consumables Division of Thermo Fisher Scientific.

• Larry Ray, chief scientist at Carestream Health.

One Buffalo-area executive was named to the board:

• Patrick Whalen, chief operating officer of Buffalo Niagara Medical Campus Inc.

One New York City-area executive was named to the board:

• Bethany Hills, a member of Epstein Becker Green.

One Boston-area executive was named to the board:

• Jeff Champagne, director of business development at MPR Associates.

View All News »